Literature DB >> 18373568

Influence exerted on drug prescribing by patients' attitudes and expectations and by doctors' perception of such expectations: a cohort and nested case-control study.

Eugenia Lado1, Manuel Vacariza, Carlos Fernández-González, Juan Jesús Gestal-Otero, Adolfo Figueiras.   

Abstract

RATIONALE, AIMS AND
OBJECTIVES: Although demand for medication is regarded as one of the most important factors in pharmaceutical expenditure, little is known about patients' influence on drug prescribing. This study assesses the influence exerted on drug prescribing by patients' attitudes and expectations, and by doctors' perception of such expectations.
METHOD: We conducted a population-based cohort study covering 937 subjects attending a health centre in the northwest of Spain. Prescription-drug advertising directly targeted at patients is banned in Spain. We conducted home-based interviews at the start of follow-up to assess patients' attitudes, and monthly telephone interviews during the 1-year follow-up period to assess consumption of medical drugs and medical visits. Using nested case-control study covering 127 of the cohort subjects who attended the health centre, we assessed patients' pre-consultation expectations for prescriptions, doctors' perception of such patients' expectations, and the drugs actually prescribed.
RESULTS: Of the total sample, 69.3% answered the home-based questionnaire, 77.6% completed 11 or more months of follow-up, and 100% of cohort subjects who attended the health centre responded to the pre-consultation survey conducted in the waiting room. Patients' attitudes, though not associated with prescription (P > 0.1), were, however, associated with demand for medical consultation (P < 0.01), self-medication (P < 0.01) and prescription expectations (P < 0.01). Although doctors' perception of patients' expectations did indeed show an association with drug prescribing (P = 0.001), there was no association between patients' expectations and doctors' perception of such expectations (P > 0.1), as these tended to be overestimated by doctors.
CONCLUSION: We conclude that, although doctors prescribe in accordance with what they believe their patients expect, in practice patients exert no influence on drug prescribing because their prescription expectations are misconstrued by doctors, who overestimate them.

Entities:  

Mesh:

Year:  2008        PMID: 18373568     DOI: 10.1111/j.1365-2753.2007.00901.x

Source DB:  PubMed          Journal:  J Eval Clin Pract        ISSN: 1356-1294            Impact factor:   2.431


  10 in total

1.  The use of 5-aminosalicylate for patients with Crohn's disease in a prospective European inception cohort with 5 years follow-up - an Epi-IBD study.

Authors:  Johan Burisch; Daniel Bergemalm; Jonas Halfvarson; Viktor Domislovic; Zeljko Krznaric; Adrian Goldis; Jens F Dahlerup; Pia Oksanen; Pekka Collin; Luisa de Castro; Vicent Hernandez; Svetlana Turcan; Elena Belousova; Renata D'Incà; Alessandro Sartini; Daniela Valpiani; Martina Giannotta; Ravi Misra; Naila Arebi; Dana Duricova; Martin Bortlik; Kelly Gatt; Pierre Ellul; Natalia Pedersen; Jens Kjeldsen; Karina W Andersen; Vibeke Andersen; Konstantinos H Katsanos; Dimitrios K Christodoulou; Shaji Sebastian; Luisa Barros; Fernando Magro; Jóngerð Mm Midjord; Kári R Nielsen; Riina Salupere; Hendrika Al Kievit; Gediminas Kiudelis; Juozas Kupčinskas; Mathurin Fumery; Corinne Gower-Rousseau; Ioannis P Kaimakliotis; Doron Schwartz; Selwyn Odes; Laszlo Lakatos; Peter L Lakatos; Ebbe Langholz; Pia Munkholm
Journal:  United European Gastroenterol J       Date:  2020-07-26       Impact factor: 4.623

2.  Physicians' Perspectives on Cost, Safety, and Perceived Efficacy Determine Aminosalicylate Use in Crohn's Disease.

Authors:  Christopher Ma; Carla Ascoytia; Kelly P McCarrier; Mona Martin; Brian G Feagan; Vipul Jairath
Journal:  Dig Dis Sci       Date:  2018-06-29       Impact factor: 3.199

Review 3.  Placebo interventions, placebo effects and clinical practice.

Authors:  Klaus Linde; Margrit Fässler; Karin Meissner
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-06-27       Impact factor: 6.237

4.  Determinants of quinolone versus trimethoprim-sulfamethoxazole use for outpatient urinary tract infection.

Authors:  Anna K Stuck; Martin G Täuber; Maria Schabel; Thomas Lehmann; Herbert Suter; Kathrin Mühlemann
Journal:  Antimicrob Agents Chemother       Date:  2012-01-09       Impact factor: 5.191

5.  Patients' ideas, concerns, and expectations (ICE) in general practice: impact on prescribing.

Authors:  Jan Matthys; Glyn Elwyn; Marc Van Nuland; Georges Van Maele; An De Sutter; Marc De Meyere; Myriam Deveugele
Journal:  Br J Gen Pract       Date:  2009-01       Impact factor: 5.386

6.  Health systems and sustainability: doctors and consumers differ on threats and solutions.

Authors:  Jane Robertson; Emily J Walkom; David A Henry
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

7.  Impartiality and infectious disease: Prioritizing individuals versus the collective in antibiotic prescription.

Authors:  Bernadine Dao; Thomas Douglas; Alberto Giubilini; Julian Savulescu; Michael Selgelid; Nadira S Faber
Journal:  AJOB Empir Bioeth       Date:  2019-03-25

8.  Factors determining antibiotic use in the general population: A qualitative study in Spain.

Authors:  Olalla Vazquez-Cancela; Laura Souto-Lopez; Juan M Vazquez-Lago; Ana Lopez; Adolfo Figueiras
Journal:  PLoS One       Date:  2021-02-04       Impact factor: 3.240

9.  The influence of gender concordance between general practitioner and patient on antibiotic prescribing for sore throat symptoms: a retrospective study.

Authors:  D Eggermont; M A M Smit; G A Kwestroo; R A Verheij; K Hek; A E Kunst
Journal:  BMC Fam Pract       Date:  2018-11-17       Impact factor: 2.497

10.  Referrals for uncomplicated lower back pain: a cluster parallel randomised trial of patient-centred communication to improve the management of acute back pain in primary care. A study protocol.

Authors:  Angela Schedlbauer; Larissa Burggraf; Susann Hueber; Irini-Alexia Terzakis-Snyder; Thomas Kühlein; Marco Roos
Journal:  BMJ Open       Date:  2019-10-28       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.